Objective: The Wnt signaling pathway is crucial for pulmonary development and differentiation; dysregulation of the Wnt signaling pathway may impair lung function. Indeed, single nucleotide polymorphisms (SNPs) of Wnt pathway-related genes have been suggested as risk factors for certain types of cancers. In this study, we aimed to evaluate the influence of SNPs in Wnt-related genes (TCF2, MMP9) on susceptibility to lung cancer.
INTRODUCTION
Lung cancer is one of the most commonly diagnosed cancers worldwide and causes the highest rate of morbidity and mortality of all cancers [1] . Despite the advances in both diagnosis and treatment in the last few decades, the prognosis for someone diagnosed with lung cancer remains poor [1] . The development of lung cancer is considered as a multifaceted and polygenic event. Although smoking is the most prominent etiological factor for the development of lung cancer [2] , single nucleotide polymorphisms (SNPs) have recently been identified as important factors for tumorigenesis. An increasing number of SNPs associated 111 with susceptibility to lung cancer have been discovered, suggesting that SNP is an important mechanism underlying lung cancer development [3] [4] [5] [6] .
The Wnt signaling pathway is involved in regulating cell function and tumorigenesis. It also plays a critical role in pulmonary development and differentiation [7] [8] [9] [10] , and its activation is dysregulated in lung adenocarcinoma cells [11, 12] . Recently, SNPs of Wnt signaling genes have been reported to correlate with the risk of cancer [13, 14] . We therefore hypothesized that SNPs of the Wnt pathway-related genes TCF2 and MMP9 may be associated with an increased risk for the development of lung cancer.
TCF2, also known as HNF1β, is a downstream transcription activator of the Wnt signaling pathway that is widely expressed in a variety of tissues, and it is crucial in embryonic development [15, 16] . It also regulates the expression of many other tissue-specific genes by binding the proximal region of the promoter sequences of genes such as alpha 1-antitrypsin [17, 18] , which, when overexpressed, is associated with lung cancer development [19] . Interestingly, the SNP of TCF2 is associated with renal cancer and prostate cancer [20, 21] , but the association with lung cancer remains unknown. Therefore, a better understanding of the polymorphism of TCF2, particularly its contribution to lung cancer development, is needed.
As a transcriptional target of Wnt signaling through tandem LEF/TCF binding sites, MMP9, plays an important role in regulating tumor cell behaviors, including growth, differentiation, apoptosis, migration, invasion, tumor angiogenesis, and immune surveillance [22] [23] [24] [25] . MMP9 overexpression is seen in lung cancer samples [26] , suggesting that it may contribute to cancer development. SNPs of MMP9 have been reported to correlate with susceptibility to lung cancer [26, 27] , but the data are inconsistent.
The aim of the present study was to investigate whether genetic variations of MMP9 and TCF2 contribute to increased risk of lung cancer development. We focused on three polymorphisms, TCF2 rs4430796, MMP9 rs2250889, and MMP9 rs17576, to evaluate the associations between the genotypes and the risk of lung cancer development.
MATERIALS AND METHODS

Subjects
The subjects were 135 unrelated lung cancer patients and 176 controls. All the subjects were genetically Han Chinese and were recruited from patients at the First Affiliated Hospital of Nanchang University, Nanchang, China. All lung cancer patients were confirmed by pathology tests based on clinical examination, and the control group was defined by having no history of cancer. The median ages of the patients and control group were 58.3 and 59.0 years old, respectively.
Genotyping
Genomic DNA was extracted from a 200 μl peripheral blood sample using a Genomic DNA Purification Kit (Tianamp Biotech, Beijing, China) according to the manufacturer's instructions and stored at -70  C until use. Three SNPs, rs4430796, rs17576, and rs2250889, were genotyped using SEQUENOM MassARRAY matrix-assisted laser desorption ionization-time of flight mass spectrometry platform (Sequenom, USA). Primers were designed using a semiautomated method (Assay Design3.1, Sequenom). The call rate for each assay was set at >90%.
Statistical Analysis
Hardy-Weinberg equilibrium (HWE) was examined using Haploview4.1. The characteristics of the subjects and the odds ratio (OR) were assessed using SPSS, version 13.0. The characteristics of the patients and the controls were compared using a two-sample t-test for continuous variables and Chi-square for categorical variable, with 95% confidence interval (95% CI). The associations between polymorphisms and lung cancer risk were estimated by computing the OR and 95% CI from binary logistic regression analyses with adjustment for age and gender. All the tests were two-sided, and P<0.05 was considered statistically significant.
RESULTS
The demographics of the patients and controls enrolled in this study are shown in Table 1 . No significant difference in age distribution was observed between the case and control groups (P=0.619). However, gender was significantly different between the two groups (P=0.011). So, age and gender adjustment were carried in the subsequent statistical analyses. The observed genotype frequencies for rs17576, rs2250889, and rs4430796 were in Hardy-Weinberg equilibrium in the control group, and the P values were 0.878, 0.959, and 0.656, respectively. The frequency distribution of the alleles and genotypes for the three polymorphisms is presented in Tables 2 and 3 . 
TCF2 Polymorphism and Lung Cancer
The genotype frequencies of rs4430796 were 1.6% (GG), 38.9% (AG), and 59.5% (AA) in lung cancer patients, which were significantly different from those observed in the control group. Compared with the GG genotype, the AA and AG genotypes were associated with lung cancer (adjusted OR=6.03, 95% CI: 1.30-28.09; 4.85, 95% CI: 1.02-23.01, respectively). Under the dominant model of inheritance, the AG+AA genotype had an adjusted OR (95% CI) of 5.55 (1.20-25.58; P=0.028) as compared with the homozygous GG genotype ( Table 2 ). The A allele frequency of rs4430796 was higher in patients with lung cancer than in controls (OR=1.50; 95% CI: 1.02-2.20), as shown in Table 2 .
MMP9 Polymorphism and Lung Cancer
The genotype distributions of MMP9 rs17576 and rs2250889 among lung cancer patients and healthy controls are listed in 
Linkage Disequilibrium and Interactions Analysis in TCF2 and
MMP9 Gene Polymorphisms
We used Haploview 4.1 to calculate the pairwise r 2 between SNPs. The MMP9 rs2250889 polymorphism was in linkage disequilibrium (LD) with rs17576 (r 2 =0.59). The TCF2 rs4430796 was not in LD with MMP9 rs2250889 (r 2 =0). Statistical differences in SNP-SNP interactions between TCF2 and MMP9 were examined ( Table 4) . The relationship between rs4430796 and the risk of lung cancer became insignificant when rs2250889 was considered as a covariable. Multivariate logistic regression analysis was performed. We used the data in case-control study to examine the residual effects of SNP1, while using SNP2 as a covariate, and we adjusted the results for gender and age. P<0.05 was considered significant.
DISCUSSION
SNPs are the most common inherited genetic markers, accounting for 90% of heterogeneity among individuals [28] . Recent reports have emphasized that some SNPs of Wnt signaling genes are related to the risk of cancer [13, 14] . In this study, we investigated the effects of three SNPs in two Wnt signaling genes on the development of lung cancer, including one in TCF2 (rs4430796) and two in MMP9 (rs2250889 and rs17576). The results indicated that rs4430796, rs2250889, and rs17576 were significantly associated with the occurrence of lung cancer.
TCF2 rs4430796 lies in intron 2 of the TCF2 gene; an A-to-G substitution in this region had no obvious effect on the expression of protein [21] . Recently, some papers have reported that rs4430796 is associated with prostate cancer [21, 29] and type 2 diabetes [30] . In the present study, we show an association between rs4430796 and susceptibility to lung cancer. The location of rs17576 is in the catalytic domain of MMP9, particularly in the fibronectin type II domain, which plays important roles in substrate binding [31] . For the homozygous genotype (A/A) of rs17576, Wu, et al. found a significantly increased risk for esophageal squamous cell carcinoma (ESCC) (OR=1.70, 95% CI: 0.62-4.66) [32] ; Jin, et al. reported a higher risk of death for non-small-cell lung cancer(NSCLC) (adjusted HR=1.62, 95% CI: 1.08-2.44) [27] . Our results also showed that A, as a risk allele of rs17576, increased the risk for lung cancer. The finding that the SNP rs17576 has a potential effect on the activity of this enzyme suggests a possible mechanism for the development or predisposition to lung cancer [26] . The rs2250889 is located in the haemopexin-like domain, which is an important site for binding with a metalloproteinase inhibitor [33] . The effect of the SNP rs2250889 in these functional domains has not been fully determined. Wu, et al. found that the rs2250889 GG genotype was associated with a significantly increased risk for ESCC (OR=4.08, 95% CI: 1.58-10.52) [32] . Our study indicated that G, as a risk allele of rs2250889, increased the risk for lung cancer. However, Hu, et al. found that rs17576 G and rs2250889 C as the risk alleles significantly increased the risk of lung cancer [26] . The differences in outcomes between studies may be due to differences in the ethnicity of the patients studied.
Wu, et al. reported that MMP9 is a transcriptional target of the Wnt pathway and that the β-catenin/LEF/TCF transcription factor complex can regulate the expression of MMP9 by binding its proximal promoter sequences [22] . From multivariate logistic regression analyses, we found that the effect of TCF2 rs4430796 became insignificant for the risk for lung cancer when MMP9 rs2250889 was considered as a covariate. LD was not found between MMP9 rs2250889 and TCF2 rs4430796; however, we did find an association between the two SNPs. The association between the genes caused by polymorphism may be related to the complex regulation of the signaling pathway, but the exact mechanism needs to be studied further.
In conclusion, the current study provides evidence that TCF2 rs4430796, MMP9 rs2250889, and MMP9 rs17576 may be associated with susceptibility to lung cancer, and we report an association between the rs4430796 SNP and susceptibility to lung cancer. Our findings are an important addition to previously published work on the association between the Wnt pathway and lung cancer susceptibility. Further validation with meta-analysis, functional studies of genetic variants, and mechanical studies of the association between rs4430796 and rs2250889 are necessary.
